GVK Biosciences

India engaging with EU to sort out pharma issues: Government

Talks on regulatory issues are going on between the two countries in order to expand and strengthen technical co-operation on…

March 3, 2016 10:27 IST

GVK Biosciences row: India, EU to meet on Jan 18 in Brussels

Upcoming Brussels meet between India, EU to look at the ban on around 700 pharma products which were clinically tested…

December 31, 2015 15:59 IST

Govt panel on GVK Bio data issue to submit report soon

The probe is being conducted by the committee after the European Medicines Agency alleged that during inspections of GVK Biosciences,…

September 24, 2015 00:32 IST

Govt likely to set up think tank to solve pharma sector issues

The think tank likely to be set up within the next two months

August 19, 2015 14:07 IST

After India defers talks, EU says drug ban not trade related

The EU today defended the banning of around 700 generic drugs that were tested by India’s GVK Biosciences, asserting it…

August 7, 2015 21:29 IST

European Union bans 700 generic drugs for manipulation of trials by GVK Biosciences

The European Union has banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by…

July 25, 2015 15:52 IST

India examines WTO option over EU drug suspension order

The European Medicines Agency (EMA) had in January suspended a number of medicines approved for sale in the EU

April 15, 2015 17:46 IST

India may take WTO action against EU over drug clinical trials by GVK Biosciences

India may go to the World Trade Organisation (WTO) if the European Union does not reconsider its decision to suspend…

April 15, 2015 14:52 IST

Happy of government’s proactive support: GVK BIO CEO

Commerce secy could take matter to WTO In what is probably the first instance of its kind, the Department of…

Updated: April 7, 2015 18:07 IST

GVK Biosciences, GVK Biosciences news, GVK Biosciences EMA, GVK Biosciences swiss medic, GVK Biosciences medicines, Medicines GVK Biosciences

Swissmedic examines drugs trialled by GVK Biosciences

The Swiss surveillance authority for medicines today checked for any corresponding preparations of the 700 generic…

February 7, 2015 16:09 IST

European Union regulator recommends suspension of drugs over GVK Biosciences data

The European drug regulator has recommended suspension of a number of medicines whose authorisation was mainly based…

January 24, 2015 06:15 IST

Germany bans 80 generic drugs, cites ‘insufficient’ trials by GVK

The German drug regulator has banned the sale of 80 generic medicines with immediate effect…

December 11, 2014 01:32 IST

Germany bans 80 generic drugs for insufficient trials by GVK Biosciences

Germany’s drug regulator has banned the sale of 80 generic medicines with immediate effect on the grounds that their clinical…

December 10, 2014 13:04 IST

4 European countries suspend authorisation of 25 drugs studied at GVK Biosciences

Four European countries have decided to suspend marketing authorisations of 25 drugs, which had undergone…

December 6, 2014 20:29 IST

GVK Biosciences manipulated results of generic drug trials: Reports

German drug regulators are examining whether to suspend the use of more than 100 medicines on the suspicion that they…

Updated: December 6, 2014 13:02 IST

Related News

The “Villain” who beat Vijay Mallya: How Danny Denzongpa built a secret beer empire

Not Thailand or Vietnam: This visa-free country with direct flights is the new favourite destination for Indian travellers

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zukerberg to lead Meta superintelligence labs

Who is Alexandr Wang? 28-year-old hired for 14 billion US dollar by Mark Zuckerberg to lead Meta superintelligence labs

2025 Asia Artist Awards winners list ful

10th Asia Artist Awards winners: IU, Stray Kids are Artist of the Year; IVE, Ateez snag other daesang

Aadhaar Card Update: Simple step-by-step guide to change your address online without hassle

Aadhaar Card Update: How to change address in Aadhaar Card online in simple steps

Why did RBI Governor say India’s economy is in ‘rare Goldilocks period’?

Policy23 min ago

RBI Governor Sanjay Malhotra cuts repo rate to 5.25%, describing India’s economy as a “rare Goldilocks period” with high growth and low inflation. GDP growth estimates revised to 7.3% for FY26 and inflation estimates lowered to 2%. This is expected to boost credit expansion in the banking industry.

View all shorts